Best Liver Supplement for Fatty Liver: What's Actually Proven — Vitamin E, Silymarin, NAC
Ukraine, Dnepr, st. 25 Sicheslavskaya Brigade (Rybinskaya St.), 119 ‑ 120
Ukraine, Dnepr, st. 25 Sicheslavskaya Brigade (Rybinskaya St.), 119 ‑ 120

Best Liver Supplement for Fatty Liver: What's Actually Proven — Vitamin E, Silymarin, NAC

Vitamin E 800 IU (PIVENS), silymarin 2100 mg/day, and NAC 600 mg twice daily — three substances with randomized trials in fatty liver disease. What each one does, doses, duration, and who should see a doctor first.

Best Liver Supplement for Fatty Liver: What's Actually Proven — Vitamin E, Silymarin, NAC
Of dozens of "liver supplements," three substances have been through randomized trials specifically in fatty liver disease: vitamin E 800 IU/day (PIVENS, biopsy-confirmed improvement), silymarin 2100 mg/day, and N-acetylcysteine 600 mg twice daily. I review what each one does, the doses, the duration, and who should see a doctor first.

Key points

In fatty liver disease (MASLD/NAFLD, metabolic dysfunction-associated steatotic liver disease), controlled trials exist for three substances — vitamin E, silymarin, and N-acetylcysteine (NAC). The largest proven effect comes from weight loss.

IngredientAmount per servingHow it is usefulWhat human studies showed
Vitamin E800 IU per day, 96 weeksthe only one of the three with a biopsy-confirmed effect on the liverin the PIVENS RCT in people without diabetes with biopsy-confirmed NASH — the only arm to meet the primary histologic endpoint (PMID 20427778)
Silymarin (milk thistle)700 mg 3 times a day (2100 mg), 48 weeksa complex of six major flavonolignans from milk thistlein a double-blind placebo-controlled RCT in people with NASH without cirrhosis — improved laboratory markers (PMID 28419855)
NAC (N-acetylcysteine)600 mg twice a day, 3 monthsa precursor to glutathione, the liver's key antioxidantin 30 patients with fatty liver disease, significantly reduced ALT and spleen size compared with vitamin C (PMID 22308119)
Weight loss7–10%first-line interventionhistologically regresses NASH — a larger effect than any supplement (Vilar-Gomez 2015, PMID 25865049)

How each substance helps

Vitamin E

The PIVENS trial (Pioglitazone versus Vitamin E versus Placebo, N Engl J Med 2010;362:1675–1685, PMID 20427778) was a randomized placebo-controlled trial in non-diabetic patients with biopsy-confirmed NASH. Vitamin E at 800 IU/day for 96 weeks was the only arm to meet the prespecified primary histologic endpoint — improvement on a strict liver histology scoring system.

Silymarin (milk thistle)

Silymarin is a complex of six major flavonolignans from milk thistle (Silybum marianum). A randomized double-blind placebo-controlled trial in non-cirrhotic NASH patients (Clin Gastroenterol Hepatol, PMID 28419855) used silymarin 700 mg three times daily (2100 mg/day) for 48 weeks and showed improved laboratory markers.

N-acetylcysteine (NAC)

NAC is a precursor to glutathione, the liver's key antioxidant. A controlled trial (Khoshbaten M, et al., Hepat Mon, PMID 22308119) compared NAC 600 mg twice daily to vitamin C 1000 mg twice daily in 30 patients with fatty liver disease over 3 months. NAC significantly reduced ALT and spleen size compared to vitamin C.

How to take

  • Baseline diagnostics: ALT, AST, FIB-4 (see ALT without symptoms: silent liver diseases) — supplements without a baseline fibrosis assessment are not meaningful.
  • 7–10% weight loss — first line.
  • Vitamin E 800 IU/day — discuss with a physician for confirmed NASH without diabetes, recheck at 3–6 months.
  • Silymarin 2100 mg/day (700 mg×3) — an alternative or addition, recheck ALT/AST at 8–12 weeks.
  • NAC 600 mg twice daily — for intolerance to other options or as an addition.
  • Recheck at 3–6 months — ALT, AST, and FibroScan if available.

Who should see a doctor first

Discuss any nutraceutical plan with your treating physician before starting, especially with diabetes, anticoagulant use, or planned use beyond a few months.

  • Vitamin E is not a "just in case" supplement. Long-term high-dose vitamin E (>400 IU/day) has been associated in other populations with a small increase in all-cause mortality and hemorrhagic stroke risk. PIVENS does not support benefit from continuing beyond the studied protocol: the duration is decided with a physician, not self-extended indefinitely.
  • ALT persistently above 30 U/L (men) / 19 U/L (women) not explained by alcohol or viral hepatitis.
  • Confirmed MASLD/NASH with metabolic risk factors (obesity, diabetes, dyslipidemia) — discuss vitamin E, silymarin, or NAC as part of a comprehensive protocol.
  • FIB-4 in the gray zone (1.3–2.67) — referral for FibroScan before choosing supplements.

Bottom line

Controlled data in fatty liver disease exists for three substances: vitamin E 800 IU/day (the strongest evidence base, biopsy-confirmed, in people without diabetes), silymarin 2100 mg/day, and NAC 600 mg twice daily (real RCTs of smaller scale). None replaces 7–10% weight loss — the intervention with the largest proven effect on the liver.

I assess fatty liver disease stage (ALT, AST, FIB-4, FibroScan referral when indicated) and build a protocol based on actual trial evidence, not marketing claims.

Source: Best Liver Supplement for Fatty Liver: What's Actually Proven — Vitamin E, Silymarin, NAC — universum.earth. md_pereligyn — Перелыгин Владимир Игоревич.

Come back
Request a call back